title: The management of ovarian cancer.
authors.affiliation: Department of Medical Oncology, University Hospital of Antwerp, Belgium.
authors.forename: A M
authors.initials: AM
authors.lastname: Prové
authors.forename: L Y
authors.initials: LY
authors.lastname: Dirix
authors.forename: D
authors.initials: D
authors.lastname: Schrijvers
authors.forename: A T
authors.initials: AT
authors.lastname: Van Oosterom
mesh_terms: D015295:Antigens, Tumor-Associated, Carbohydrate / Q000032:analysis; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000032:analysis; D002277:Carcinoma / Q000175:diagnosis / Q000556:secondary / Q000628:therapy*; D002945:Cisplatin / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008875:Middle Aged; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000175:diagnosis / Q000628:therapy*
chemical_list: D015295:Antigens, Tumor-Associated, Carbohydrate; D014408:Biomarkers, Tumor; D003520:Cyclophosphamide; D002945:Cisplatin